Hosted on MSN1mon
Baxter targets 5%-6% 2025 revenue growth amid Novum IQ pump success and operational recoveryBaxter International ended 2024 on a positive note, overcoming challenges posed by Hurricane Helene and delivering better-than-expected Q4 results. The success of the Novum IQ infusion pump ...
GlobalData on MSN1mon
FDA issues early alert for Baxter’s Spectrum infusion pumpThe US Food and Drug Administration (FDA) has issued an early alert over a ‘potentially high-risk’ issue with certain Baxter ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback